Liraglutide and Cardio-Metabolic Risk Markers (opens ClinicalTrials.gov)
- Sponsor
- University of Palermo
- Enrolment
- 300
- Started
- 2012-06
- Last update
- 2017-11-22
Conditions: Type-2 Diabetes
Research discovery
— registered studies
Verify this search on the official site ↗ · fetched Nov 5, 2026, 12:35 PM UTC
Status on this page
A registered trial is a plan, not a result. “Results posted” means the sponsor uploaded summary results to the registry; it says nothing about whether the treatment worked.
Conditions: Type-2 Diabetes
Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: liraglutide, placebo
Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: liraglutide, orlistat, placebo
Conditions: Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea
Interventions: liraglutide, placebo
Conditions: Obesity
Interventions: Liraglutide, Placebo
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: insulin degludec/liraglutide, placebo
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: insulin degludec, placebo, liraglutide
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: insulin degludec/liraglutide
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: liraglutide
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: liraglutide, metformin, sulphonylurea
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: liraglutide
Conditions: T2DM (Type 2 Diabetes Mellitus), Fatty Liver, NAFLD
Interventions: Non-interventional
Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: liraglutide
Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: NNC9204-0530, liraglutide, placebo
Conditions: Psoriatic Arthritis, Psoriasis, Impaired Glucose Tolerance, Type 2 Diabetes
Interventions: liraglutide, Placebo
Conditions: Diabetes Mellitus, Type 2
Interventions: sitagliptin, liraglutide, glimepiride, metformin
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: liraglutide, sitagliptin
Conditions: Diabetes, Effects of Liraglutide Administration on Brain Activity, Weight Loss, Hunger
Interventions: Liraglutide, Placebo
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: insulin degludec/liraglutide
Conditions: Binge Eating Behaviour
Interventions: Liraglutide, Diet and Exercise